Researchers Discover New Target for Alzheimer's Treatment with Innovative Compound

Buzzline

Scientists at Vanderbilt University's Warren Center for Neuroscience Drug Discovery have developed the inaugural selective compound capable of deactivating TAOK-1, a little-known protein associated with Alzheimer's disease. Under the guidance of Craig Lindsley, the research team evaluated over 150,000 molecules, ultimately isolating VU6083859, the first tool refined enough to investigate TAOK-1's impact on tau protein degradation within living neurons. Additionally, an unforeseen compound was identified that activates the entire TAOK protein family, providing a unique dual-tool system for exploring both aspects of the pathway. Alzheimer's disease currently affects over 7 million individuals in the United States and lacks a definitive cure, with available treatments merely alleviating symptoms. The researchers assert that these new compounds, detailed in ACS Chemical Neuroscience, may pave the way for a novel class of medications that address the fundamental molecular origins of the disease, rather than merely its symptoms.  Disclosure: This video contains stock footage and content created or enhanced using AI-assisted tools.  ai-generated

Transcript

00:00Scientists just unlocked a target inside the brain that researchers have been trying to study for years.

00:05And couldn't, because the right tool didn't exist, until now.

00:10A team at Vanderbilt University's Warren Center for Neuroscience Drug Discovery

00:14has created the first-ever compound that selectively controls Tiaok-1,

00:19a protein now linked to Alzheimer's disease.

00:23Researchers screened more than 150,000 molecules to find it.

00:27Tiaok-1 helps regulate, though, the protein that tangles and destroys brain cells in Alzheimer's.

00:33But because there was never a precise chemical tool to study it, its exact role stayed a mystery.

00:38This new compound, called VA-is083859,

00:43finally lets scientists watch what happens when they switch Tiaok-1 off inside living neurons.

00:49And in a twist researchers didn't expect, a second compound they created did the opposite,

00:54activating the entire Tiaok protein family at once,

00:58giving them a rare two-way probe to study the pathway from both directions.

01:03Alzheimer's disease affects more than 7 million Americans and still has no cure.

01:08Current drugs only slow symptoms down.

01:10Scientists say these new tools, published this month in ACS Chemical Neuroscience,

01:15could become the starting point for the next generation of Alzheimer's treatments.

01:19That target the disease's root cause, instead of just managing its symptoms.

01:25Disclosure.

01:25This video contains stock footage and content created or enhanced using AI-assisted tools.

Category

Transcript

Comments

Recommended